semaglutide off shortage list ends as FDA sets deadline for compounders Semaglutide and Tirzepatide off FDA

CASTA, the Cerebrolysin Acute Stroke Treatment in Asia trial, randomized 1,070 patients within twelve hours of an ischemic stroke to either 30 mL of cerebrolysin a day for ten days on top of aspirin, or to a saline placebo (Heiss et al., Stroke 2012, phase 3)

Over 7,000 subscribers Subscribe By subscribing, you agree Substack's Terms of Use , and acknowledge its Information Collection Notice and Privacy Policy

:

The primary materials discussed are various angiotensin peptides, their synthetic analogs, and specific receptor antagonists, while the methods encompass biochemical assays, animal models of neurodegenerative diseases, and behavioral assessments [2]